| |
| |
|
| Insider
Information: |
Shukla Sath |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,256,507 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,730,543 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,256,507 |
|
|
| Total
Value |
$1,730,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alaunos Therapeutics |
TCRT |
EVP, Chief Financial O... |
2020-01-29 |
80,500 |
2020-01-29 |
0 |
Premium* |
|
|
Spero Therapeutics Inc |
SPRO |
|
2024-02-05 |
1,176,007 |
2021-08-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2024-02-05 |
4 |
AS |
$1.45 |
$65,385 |
D/D |
(45,093) |
1,176,007 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2024-02-02 |
4 |
AS |
$1.37 |
$42,334 |
D/D |
(30,901) |
1,221,100 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
679,501 |
1,252,001 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2023-08-29 |
4 |
AS |
$1.30 |
$5,412 |
D/D |
(4,163) |
572,500 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2023-08-28 |
4 |
AS |
$1.26 |
$2,336 |
D/D |
(1,854) |
576,663 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2023-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
266,000 |
578,517 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-02-02 |
4 |
AS |
$1.83 |
$17,372 |
D/D |
(9,504) |
312,517 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
265,957 |
322,021 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-08-29 |
4 |
AS |
$0.89 |
$5,378 |
D/D |
(6,017) |
56,064 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,014 |
62,081 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,067 |
24,067 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
EVP, Chief Financial Officer |
• – – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
80,500 |
80,500 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
